Indian Heart Journal (Jul 2023)

Effectiveness and safety of optical coherence tomography-guided PCI in Indian patients with complex lesions: A multicenter, prospective registry

  • Praveen Chandra,
  • Selvamani Sethuraman,
  • Sanjeeb Roy,
  • Arun Mohanty,
  • Keyur Parikh,
  • Bahuleyan Charantharalyil Gopalan,
  • Prasant Kumar Sahoo,
  • Sridhar Kasturi,
  • Vijay Trambaklal Shah,
  • Viveka Kumar,
  • Brian Pinto,
  • Pratap Chandra Rath,
  • Vijayachandra Reddy Yerramareddy,
  • Deepak Davidson,
  • Girish B. Navasundi,
  • Vijayakumar Subban,
  • Nandhini Livingston,
  • Deva Preethi Rajaraman,
  • Manish Narang,
  • Nick E.J. West,
  • Ajit Mullasari

Journal volume & issue
Vol. 75, no. 4
pp. 236 – 242

Abstract

Read online

Background: Optical coherence tomography (OCT) is reported to be a feasible and safe imaging modality for the guidance of percutaneous coronary intervention (PCI) of complex lesions. Methods: This multicenter, prospective registry assessed the minimum stent area (MSA) achieved under OCT guidance. A performance goal of 24% improvement in MSA over and above the recommendation set by the European Association of Percutaneous Cardiovascular Interventions Consensus 2018 (4.5 mm2 MSA for non-left main and 3.5 mm2 for small vessels). The incidence of contrast-induced nephropathy was also assessed. Core lab analysis was conducted. Results: Five hundred patients (average age: 59.4 ± 10.1 years; 83% males) with unstable angina (36.8%), NSTEMI (26.4%), and STEMI (22%) were enrolled. The primary endpoint was achieved in 93% of lesions with stent diameter ≥2.75 mm (average MSA: 6.44 mm2) and 87% of lesions with stent diameter ≤2.5 mm (average MSA: 4.56 mm2). The average MSA (with expansion ≥80% cutoff) was 6.63 mm2 and 4.74 mm2 with a stent diameter ≥2.75 mm and ≤2.5 mm, respectively. According to the core lab analysis, the average MSA achieved with a stent diameter ≥2.75 mm and ≤2.5 mm was 6.23 mm2 and 3.95 mm2, respectively (with expansion ≥80% cutoff). Clinically significant serum creatinine was noted in two patients (0.45%). Major adverse cardiac events at 1 year were noted in 1.2% (n = 6) of the patients; all were cardiac deaths. Conclusion: PCI under OCT guidance improves procedural and long-term clinical outcomes in patients with complex lesions not just in a controlled trial environment but also in routine clinical practice.

Keywords